Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $46.8600 (0.3%) ($46.8200 - $47.4950) on Fri. Jul. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 63 | Latest Price | $46.8600(0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.7% a day on average for past five trading days. | Weekly Trend | BAX advances 1.6% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) GLD(70%) DIA(46%) SDY(46%) SPLV(45%) XLF(45%) | Factors Impacting BAX price | BAX will decline at least -0.785% in a week (0% probabilities). UUP(-39%) VXX(-35%) VIXM(-31%) TBT(-20%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $46.33(1.14%) | 10 Day Moving Average | $45.83(2.25%) | 20 Day Moving Average | $45.42(3.17%) | To recent high | -1.7% | To recent low | 16.2% | Market Cap | $23.907b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |